1. Home
  2. PRPO vs APVO Comparison

PRPO vs APVO Comparison

Compare PRPO & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • APVO
  • Stock Information
  • Founded
  • PRPO N/A
  • APVO 2016
  • Country
  • PRPO United States
  • APVO United States
  • Employees
  • PRPO N/A
  • APVO N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPO Industrials
  • APVO Health Care
  • Exchange
  • PRPO Nasdaq
  • APVO Nasdaq
  • Market Cap
  • PRPO 9.9M
  • APVO 6.5M
  • IPO Year
  • PRPO N/A
  • APVO N/A
  • Fundamental
  • Price
  • PRPO $6.89
  • APVO $4.00
  • Analyst Decision
  • PRPO
  • APVO Strong Buy
  • Analyst Count
  • PRPO 0
  • APVO 1
  • Target Price
  • PRPO N/A
  • APVO $296.00
  • AVG Volume (30 Days)
  • PRPO 6.8K
  • APVO 46.8K
  • Earning Date
  • PRPO 03-28-2025
  • APVO 03-04-2025
  • Dividend Yield
  • PRPO N/A
  • APVO N/A
  • EPS Growth
  • PRPO N/A
  • APVO N/A
  • EPS
  • PRPO N/A
  • APVO N/A
  • Revenue
  • PRPO $17,411,000.00
  • APVO N/A
  • Revenue This Year
  • PRPO $75.18
  • APVO N/A
  • Revenue Next Year
  • PRPO N/A
  • APVO N/A
  • P/E Ratio
  • PRPO N/A
  • APVO N/A
  • Revenue Growth
  • PRPO 31.31
  • APVO N/A
  • 52 Week Low
  • PRPO $4.31
  • APVO $3.65
  • 52 Week High
  • PRPO $7.20
  • APVO $399.60
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 61.15
  • APVO 36.27
  • Support Level
  • PRPO $6.65
  • APVO $3.91
  • Resistance Level
  • PRPO $6.90
  • APVO $4.47
  • Average True Range (ATR)
  • PRPO 0.23
  • APVO 0.30
  • MACD
  • PRPO 0.02
  • APVO 0.05
  • Stochastic Oscillator
  • PRPO 84.72
  • APVO 18.40

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: